Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN
Simultaneous radio-chemotherapy in advanced non-small cell lung cancer. The study focusses on a randomised comparison of conventional radiotherapy planning with irradiation of macroscopic tumor and lymph nodes together with prophylactic target volumes vs. irradiation only of FDG-positive lesions.
Primary endpoint is the local disease control in the chest
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
histologically proved NSCLC
UICC-stage I-III, no resection planned
complete staging \< 6 wks before treatment including cranial CT
ECOG \<3, Karnofsky-Index \>60%
age \> 18 \<
FEV1 \> 1,0 l or \>35%
RT-planning according to protocol feasible
chemotherapy feasible
written informed consent
You may not be if
neuroendocrine tumors, plain broncho-alveolar-cell ca.
